MeSH D005128 - eye diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005128:
Eye diseases
0 Companies
0 Drugs
Success rate
D001248:Asthenopia
0 Companies
0 Drugs
Success rate
D003229:Conjunctival diseases
0 Companies
0 Drugs
Success rate
D003316:Corneal diseases
D005124:Eye abnormalities
0 Companies
0 Drugs
Success rate
D005130:Eye hemorrhage
0 Companies
0 Drugs
Success rate
D005131:Eye injuries
0 Companies
0 Drugs
Success rate
D005132:Eye manifestations
0 Companies
0 Drugs
Success rate
D005134:Eye neoplasms
0 Companies
0 Drugs
Success rate
D005141:Eyelid diseases
0 Companies
0 Drugs
Success rate
D007766:Lacrimal apparatus diseases
0 Companies
0 Drugs
Success rate
D007905:Lens diseases
0 Companies
0 Drugs
Success rate
D009798:Ocular hypertension
D009901:Optic nerve diseases
0 Companies
0 Drugs
Success rate
D009916:Orbital diseases
0 Companies
0 Drugs
Success rate
D011681:Pupil disorders
0 Companies
0 Drugs
Success rate
D012030:Refractive errors
0 Companies
0 Drugs
Success rate
D012164:Retinal diseases
D014603:Uveal diseases
0 Companies
0 Drugs
Success rate
D014786:Vision disorders
0 Companies
0 Drugs
Success rate
D015422:Scleral diseases
0 Companies
0 Drugs
Success rate
D015785:Hereditary eye diseases
0 Companies
0 Drugs
Success rate
D015814:Ocular hypotension
0 Companies
0 Drugs
Success rate
D015817:Eye infections
0 Companies
0 Drugs
Success rate
D015835:Ocular motility disorders
0 Companies
0 Drugs
Success rate
D020255:Vitreous detachment
0 Companies
0 Drugs
Success rate
D055952:Cogan syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
60%6/10
Phase 2
44%7/16
Phase 3
11%2/18
Approved: 0Overall Success rate: 3%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use